Search Results - "BOLLING‐STERNEVALD, E."

Refine Results
  1. 1

    Functional dyspepsia impairs quality of life in the adult population by Aro, P., Talley, N. J., Agréus, L., Johansson, S.‐E., BollingSternevald, E., Storskrubb, T., Ronkainen, J.

    Published in Alimentary pharmacology & therapeutics (01-06-2011)
    “…Aliment Pharmacol Ther 2011; 33: 1215–1224 Summary Background  Data on the impact of functional dyspepsia on health‐related quality of life in the general…”
    Get full text
    Journal Article
  2. 2

    Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study by Ronkainen, Jukka, Talley, Nicholas J, Aro, Pertti, Storskrubb, Tom, Johansson, Sven-Erik, Lind, Tore, Bolling-Sternevald, Elisabeth, Vieth, Michael, Stolte, Manfred, Walker, Marjorie M, Agréus, Lars

    Published in Gut (01-05-2007)
    “…Background: Eosinophilic oesophagitis may be increasing but the prevalence in the general population remains unknown. Our aim was to assess this and the…”
    Get full text
    Journal Article
  3. 3

    Gastro‐oesophageal reflux symptoms and health‐related quality of life in the adult general population – the Kalixanda study by RONKAINEN, J., ARO, P., STORSKRUBB, T., LIND, T., BOLLINGSTERNEVALD, E., JUNGHARD, O., TALLEY, N. J., AGREUS, L.

    Published in Alimentary pharmacology & therapeutics (15-06-2006)
    “…Summary Background The impact of gastro‐oesophageal reflux symptoms on health‐related quality of life in the general population is poorly characterized. Aim To…”
    Get full text
    Journal Article
  4. 4

    Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole – results from the STARS II study by Veldhuyzen van Zanten, S., Wahlqvist, P., Talley, N. J., Halling, K., Vakil, N., Lauritsen, K., Flook, N., Persson, T., BollingSternevald, E.

    Published in Alimentary pharmacology & therapeutics (01-10-2011)
    “…Aliment Pharmacol Ther 2011; 34: 714–723 Summary Background  Patients with dyspepsia often experience troublesome symptoms. Aim  To assess the burden of…”
    Get full text
    Journal Article
  5. 5

    The Usefulness of a Structured Questionnaire in the Assessment of Symptomatic Gastroesophageal Reflux Disease by Carlsson, R, Dent, J, Bolling-Sternevald, E, Johnsson, F, Junghard, O, Lauritsen, K, Riley, S, Lundell, L

    “…Background: The diagnosis of gastroesophageal reflux disease (GERD) rests primarily on recognition of symptom patterns that are classical for reflux disease,…”
    Get full text
    Journal Article
  6. 6

    Randomized‐controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1‐week trial of acid suppression predict symptom response? by TALLEY, N. J, VAKIL, N., LAURITSEN, K., VAN ZANTEN, S. V., FLOOK, N., BOLLINGSTERNEVALD, E., PERSSON, T., BJÖRCK, E., LIND, T.

    Published in Alimentary pharmacology & therapeutics (01-09-2007)
    “…Summary Background Early identification of true responders to acid suppression in functional dyspepsia patients with symptoms of epigastric pain or burning may…”
    Get full text
    Journal Article
  7. 7

    Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro‐oesophageal reflux disease in Western patients with non‐ulcer dyspepsia by VAKIL, N., TALLEY, N. J., STOLTE, M., SUNDIN, M., JUNGHARD, O., BOLLINGSTERNEVALD, E.

    Published in Alimentary pharmacology & therapeutics (01-07-2006)
    “…Summary Background The effect of Helicobacter pylori eradication on the development of gastro‐oesophageal reflux disease is controversial. Aim To determine the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia? by BollingSternevald, E., Lauritsen, K., Talley, N. J., Junghard, O., Glise, H.

    Published in Alimentary pharmacology & therapeutics (01-07-2003)
    “…Summary Background: The efficacy of proton pump inhibitors in functional dyspepsia is modest and the prognostic factors are almost unknown. Methods: Data were…”
    Get full text
    Journal Article
  10. 10

    Effect of Profound Acid Suppression in Functional Dyspepsia: a Double-Blind, Randomized, Placebo-Controlled Trial by Bolling-Sternevald, E., Lauritsen, K., Aalykke, C., Havelund, T., Knudsen, T., Unge, P., Ekström, P., Jaup, B., Norrby, A., Stubberöd, A., Melén, K., Carlsson, R., Jerndal, P., Junghard, O., Glise, H.

    “…Background: Functional dyspepsia (FD) is defined as persistent or recurrent pain/discomfort centred in the upper abdomen, where no structural explanation for…”
    Get full text
    Journal Article
  11. 11

    Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study by Aro, P, Ronkainen, J, Talley, N J, Storskrubb, T, Bolling-Sternevald, E, Agréus, L

    Published in Gut (01-10-2005)
    “…Background: We aimed to determine whether obese subjects experience more gastro-oesophageal reflux (GORS) symptoms than normal subjects, and further to…”
    Get full text
    Journal Article
  12. 12

    Clinical and pathological implications of IgG antibody responses to Helicobacter pylori and its virulence factors in non-ulcer dyspepsia by XIA, H. H.-X, TALLEY, N. J, BLUM, A. L, O'MORAIN, C. A, STOLTE, M, BOLLING-STERNEVALD, E, MITCHELL, H. M

    Published in Alimentary pharmacology & therapeutics (01-04-2003)
    “…To determine whether pre-treatment antibody response to Helicobacter pylori virulence factors predicts eradication success and symptom relief 12 months after…”
    Get full text
    Journal Article
  13. 13

    Impact of Functional Dyspepsia on Quality of Life and Health Care Consumption after Cessation of Antisecretory Treatment: A Multicentre 3-Month Follow-up Study by Meineche-Schmidt, V, Talley, N J, Pap, A, Kordecki, H, Schmid, V, Ohlsson, L, Wahlqvist, P, Wiklund, I, Bolling-Sternevald, E

    “…Background: The impact of response to treatment on subsequent symptoms, quality of life, health care consumption, and absence from work in functional dyspepsia…”
    Get full text
    Journal Article
  14. 14

    Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study by Aro, P., Ronkainen, J., Storskrubb, T., Bolling-Sternevald, E., Carlsson, R., Johansson, S.-E., Vieth, M., Stolte, M., Engstrand, L., Talley, N. J., Agréus, L.

    “…Background: Upper oesophagogastroduodenoscopy is considered to be the gold standard for upper gastrointestinal disease assessment, but is currently seldom used…”
    Get full text
    Journal Article
  15. 15

    Do gastrointestinal symptoms fluctuate in the short-term perspective? The Kalixanda study by Bolling-Sternevald, E, Aro, P, Ronkainen, J, Storskrubb, T, Talley, N J, Junghard, O, Agréus, L

    Published in Digestive diseases (Basel) (01-01-2008)
    “…Short-term fluctuation of gastrointestinal symptoms in the general population is largely unknown. We aimed to determine gastrointestinal symptom fluctuation in…”
    Get more information
    Journal Article
  16. 16

    Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up by Talley, Nicholas J, Janssens, Jef, Lauritsen, Karsten, Rácz, István, Bolling-Sternevald, Elisabeth

    Published in BMJ (27-03-1999)
    “…Abstract Objectives: To determine whether eradication of Helicobacter pylori relieves the symptoms of functional dyspepsia. Design: Multicentre randomised…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms? by Veldhuyzen van Zanten, S J O, Talley, N J, Blum, A L, Bolling-Sternevald, E, Sundin, M, Junghard, O

    Published in Gut (01-05-2002)
    “…Currently, one of the most important unresolved questions concerning Helicobacter pylori is whether eradication of the organism leads to a sustained…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    Prevalence of Barrett’s Esophagus in the General Population: An Endoscopic Study by Ronkainen, Jukka, Aro, Pertti, Storskrubb, Tom, Johansson, Sven–Erik, Lind, Tore, Bolling–Sternevald, Elisabeth, Vieth, Michael, Stolte, Manfred, Talley, Nicholas J., Agréus, Lars

    Published in Gastroenterology (New York, N.Y. 1943) (01-12-2005)
    “…Background & Aims: Barrett’s esophagus (BE) is associated with esophageal adenocarcinoma, the incidence of which has been increasing dramatically. The…”
    Get full text
    Journal Article
  20. 20

    Anxiety Is Associated With Uninvestigated and Functional Dyspepsia (Rome III Criteria) in a Swedish Population-Based Study by Aro, Pertti, Talley, Nicholas J, Ronkainen, Jukka, Storskrubb, Tom, Vieth, Michael, Johansson, Sven–Erik, Bolling–Sternevald, Elisabeth, Agréus, Lars

    “…Background & Aims The Rome III criteria for functional dyspepsia have been changed to include 2 distinct syndromes: postprandial distress syndrome and…”
    Get full text
    Journal Article